The firm said that in a first phase of the contract it will focus on further development of its fever test that analyzes immune system gene expression patterns.
The firm is developing the test under a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.
The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.
The organizations noted in a letter to HHS and FDA that they "believe the agency's actions may in fact inflict greater harm on patients and impede innovation."
The award will fund optimization of the Hemopurifier exosome isolator, with an eye towards developing applications in cancer research and clinical care.
The company decided to settle the complaint in order to avoid "lengthy and distracting litigation," but denies any wrongdoing.
US health officials have issued a fraud alert for a scam involving genetic testing, Bloomberg reports.
The Trump Administration has curbed fetal tissue research in the US, the New York Times reports.
Proposals from two HHS agencies look to encourage patient access to data and interoperability in research and clinical practice, including Sync for Genes.
ScienceInsider reports that some risky flu studies that came to a halt a few years back may soon resume.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.